Chemistry: molecular biology and microbiology – Measuring or testing process involving enzymes or... – Involving antigen-antibody binding – specific binding protein...
Reexamination Certificate
2008-04-22
2008-04-22
Rawlings, Stephen L. (Department: 1643)
Chemistry: molecular biology and microbiology
Measuring or testing process involving enzymes or...
Involving antigen-antibody binding, specific binding protein...
C530S350000, C530S388230, C436S064000
Reexamination Certificate
active
10644797
ABSTRACT:
The present invention provides methods for detecting, diagnosing or prognosticating prostate cancer by measuring the levels of macrophage migration inhibitory factor (MIF) in the serum of an individual. The assay for MIF can be an immunoassay, such as ELISA, or a nucleic assay, such as Nouthern blot. Genetic changes within MIF gene can predict patients that express high levels of MIF.
REFERENCES:
patent: 5250297 (1993-10-01), Grauer et al.
patent: 5614372 (1997-03-01), Lilja et al.
patent: 5654161 (1997-08-01), Tewari
patent: 6043044 (2000-03-01), Hudson et al.
patent: 6268151 (2001-07-01), Murray et al.
patent: 6420188 (2002-07-01), Bucala et al.
Zhang et al. (Hepatobiliary Pancreat. Dis. Int. Nov. 2002; 1 (4): 577-580).
Mitamura et al. (Br. J. Ophthalmol. 2000; 84: 636-639).
Leech et al. (Arthritis Rheumatol. Apr. 2000; 43 (4): 827-833).
Wright et al. (Prostate Cancer Prostatic Dis. Dec. 1999; 2 (5/6): 264-76).
Meyer-Siegler et al. (Urology. 1996; 48: 448-452).
Meyer-Siegler et al. (J. Interferon Cytokine Res. 2000; 20: 769-778).
Koong et al. (Cancer Res. Feb. 15, 2000; 60: 883-887).
Arcuri et al. (Prostate. 1999; 39: 159-165).
Meyer-Siegler et al. (BMC Cancer. Jul. 6, 2005; 5 (1): 73; copy of electronically published document, pp. 1-12).
Maaser et al. (Gastroenterology. Mar. 2002; 122 (3): 667-680).
Meyer-Siegler et al. (Diagn. Mol. Pathol. Feb. 1998; 7 (1): 44-50).
He et al. (Gut. 2006; 55: 797-802).
Muramaki et al. (Oncol. Rep. 2006; 15: 253-257).
Michael et al. (Prostate. 205; 62: 34-39).
Kitaichi et al. (Graefe's Arch. Clin. Exp. Ophthalmol. 2006; 244: 825-828).
Chen et al. (Am. J. Trop. Med. Hyg. 2006; 74 (1): 142-147).
Kibiki et al. (Clin. Immunol. 2007; in press; copy of electronically published document, pp. 1-6).
Rahman et al. (Annals Surg. Feb. 2007; 245 (2): 282-289).
Yanagi et al. (Cytokine. 2006; 35: 270-274).
Stephan et al. (Prostate. 2006; 66: 651-659).
Vandenbroeck et al. 2003. Cytokine gene polymorphism in multifactorial diseases: gateways to novel targets for immunotherapy? TRENDS in Pharmacol. Sci. 24(6):284-289.
Meyer-Siegler et al. 2002. Macrophage migration inhibitory factor evaluation compared with prostate specific antigen as a biomarker in patients with prostate carcinoma. Cancer. 94(5):1449-1456.
Michael, Anja et al, “Serum Macrophage Migration Inhibitory Factor Is Not Elevated in Patients with Prostate Cancer”. Cancer Epidemiology, Biomarkers & Prevention, vol. 13, pp. 328-329, Feb. 2004.
Li, Haojie et al, “Prediagnostic Plasma Vascular Endothelial Growth Factor Levels and Risk of Prostate Cancer”. Cancer Epidemiology, Biomarkers & Prevention, Jun. 2005 vol. 14(6), pp. 1557-1561.
Yousef, G. M. et al, “Differential Expression of the Human Kallikrein Gene 14 (KLK14) in Normal and Cancerous Prostatic Issues”. Prostate, Sep. 1, 2003 vol. 56(4), pp. 287-292.
Borgono, Carla A. “Human Kallikrein 14: A New Potential Biomarker for Ovarian and Breast Cancer”. Cancer Research vol. 63, Dec. 15, 2003, pp. 9032-9041.
Blank Rome LLP
Rawlings Stephen L.
United States of America as represented by The Department of Vet
LandOfFree
Serum macrophage migration inhibitory factor (MIF) as marker... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Serum macrophage migration inhibitory factor (MIF) as marker..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Serum macrophage migration inhibitory factor (MIF) as marker... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3955040